Your browser doesn't support javascript.
loading
Establishment of a Nipah Virus Disease Model in Hamsters, including a Comparison of Intranasal and Intraperitoneal Routes of Challenge.
Findlay-Wilson, Stephen; Flett, Lucy; Salguero, Francisco J; Ruedas-Torres, Ines; Fotheringham, Susan; Easterbrook, Linda; Graham, Victoria; Dowall, Stuart.
Afiliação
  • Findlay-Wilson S; United Kingdom Health Security Agency (UKHSA), Porton Down, Salisbury SP4 0JG, UK.
  • Flett L; United Kingdom Health Security Agency (UKHSA), Porton Down, Salisbury SP4 0JG, UK.
  • Salguero FJ; United Kingdom Health Security Agency (UKHSA), Porton Down, Salisbury SP4 0JG, UK.
  • Ruedas-Torres I; United Kingdom Health Security Agency (UKHSA), Porton Down, Salisbury SP4 0JG, UK.
  • Fotheringham S; United Kingdom Health Security Agency (UKHSA), Porton Down, Salisbury SP4 0JG, UK.
  • Easterbrook L; United Kingdom Health Security Agency (UKHSA), Porton Down, Salisbury SP4 0JG, UK.
  • Graham V; United Kingdom Health Security Agency (UKHSA), Porton Down, Salisbury SP4 0JG, UK.
  • Dowall S; United Kingdom Health Security Agency (UKHSA), Porton Down, Salisbury SP4 0JG, UK.
Pathogens ; 12(8)2023 Jul 26.
Article em En | MEDLINE | ID: mdl-37623936
ABSTRACT
Nipah virus (NiV) is an emerging pathogen that can cause severe respiratory illness and encephalitis in humans. The main reservoir is fruit bats, distributed across a large geographical area that includes Australia, Southeast Asia, and Africa. Incursion into humans is widely reported through exposure of infected pigs, ingestion of contaminated food, or through contact with an infected person. With no approved treatments or vaccines, NiV poses a threat to human public health and has epidemic potential. To aid with the assessment of emerging interventions being developed, an expansion of preclinical testing capability is required. Given variations in the model parameters observed in different sites during establishment, optimisation of challenge routes and doses is required. Upon evaluating the hamster model, an intranasal route of challenge was compared with intraperitoneal delivery, demonstrating a more rapid dissemination to wider tissues in the latter. A dose effect was observed between those causing respiratory illness and those resulting in neurological disease. The data demonstrate the successful establishment of the hamster model of NiV disease for subsequent use in the evaluation of vaccines and antivirals.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pathogens Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pathogens Ano de publicação: 2023 Tipo de documento: Article